Binbin Tian
Study Director

Is this your profile?

About

Binbin Tian is a Study Director in the drug metabolism and pharmacokinetic service department at WuXi AppTec. She holds an MS in Pharmaceutical Science, and her expertise is in preclinical pharmacokinetics, specifically
ocular pharmacokinetic evaluation

Contributions

REVOLUTIONISING EYE CARE: THE POTENTIAL OF ANTISENSE OLIGONUCLEOTIDES

Binbin Tian discusses antisense oligonucleotides and considers their potential as treatments for genetic and multifactorial ophthalmic diseases previously considered untreatable. The article considers how these therapies function as treatments, their current state of development, challenges in their delivery and the evolving regulatory landscape

More contributions

OVERCOMING CHALLENGES WHEN DEVELOPING OLIGONUCLEOTIDES FOR OPHTHALMIC DRUGS

Shiyan Chen and Binbin Tian discuss the use of oligonucleotides for ophthalmic applications, including their potential uses, advantages, challenges and difficulties when it comes to pharmacokinetic and drug metabolism studies.

Top